These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7234245)

  • 1. [Safety, antigenic activity, and epidemiologic effectiveness of live mumps vaccine from strain Leningrad-3. I. Reactogenic, allergenic and mutagenic properties of the vaccine and its effect on the body's resistance to intercurrent diseases].
    Grazhdanov NP; Popov VF; Sokhin AA; Salmin LV; Frolov AK
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jan; (1):69-74. PubMed ID: 7234245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety, antigenic activity, and epidemiologic effectiveness of live mumps vaccine from strain L-3. II. Antigenic activity and epidemiologic effectiveness].
    Brazhdanov NP; Popov VF; Sokhin AA; Salmin LV; Frolov VK
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Feb; (2):45-51. PubMed ID: 7245955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Patterns of the cytogenetic changes in the peripheral blood lymphocytes of children immunized against smallpox and parotitis].
    Frolov AK
    Tsitologiia; 1979 Feb; 21(2):202-6. PubMed ID: 432960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of mumps in preschool institutions using a live mumps vaccine made from strain L-3].
    Garaseferian MG; Bolotovskiĭ VM; Shatrova LP; Titova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Apr; (4):39-42. PubMed ID: 2970740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of smallpox vaccines from strains B-51, EM-63 and L-IVP in a controlled epidemiologic trial. I. Reactogenic characteristics of the smallpox vaccines].
    Khliabich GN; Sumarokov AA; Ozeretskovskiĭ NA; Karinskaia GA; Gurvich EB
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Aug; (8):20-6. PubMed ID: 217209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smallpox vaccination and adverse reactions. Guidance for clinicians.
    Cono J; Casey CG; Bell DM;
    MMWR Recomm Rep; 2003 Feb; 52(RR-4):1-28. PubMed ID: 12617510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Testing for the safety, reactogenicity and antigenic properties of a live thermostable mumps vaccine made from the Leningrad-3 strain].
    Iuminova HV; Liashenko VA; Krasnova VP; Krivenkova VN; Goliazhenkova MIu; Unanov SS
    Vopr Virusol; 1991; 36(4):310-2. PubMed ID: 1796587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of studying a live mumps vaccine from strain L-3 manufactured by the Moscow Research Institute of Viral Preparations. The reactogenic and antigenic properties of the vaccine].
    Unanov SS; Bochkov RA; Alekseeva AK; Kaptsova TI; Levchenko EN
    Vopr Virusol; 1977; (1):54-8. PubMed ID: 333761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccination in childhood].
    Spiess H
    Dtsch Med Wochenschr; 1972 Jan; 97(4):125-31. PubMed ID: 4550326
    [No Abstract]   [Full Text] [Related]  

  • 10. A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids.
    Nakayama T; Aizawa C; Kuno-Sakai H
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):321-5. PubMed ID: 9949325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous administration of a diphtheria and tetanus toxoids and acellular pertussis vaccine with measles-mumps-rubella and oral poliovirus vaccines.
    Rothstein EP; Bernstein HH; Glode MP; Laussucq S; Nonenmacher J; Long SS; Hackell JG
    Am J Dis Child; 1993 Aug; 147(8):854-7. PubMed ID: 8394646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles and mumps immunization: benefit versus risk factors.
    Krugman S
    Dev Biol Stand; 1979; 43():253-7. PubMed ID: 520672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Virus strain specific serum neutralizing antibodies in children and adolescents immunized with a Russian mumps vaccine].
    Otrashevskaia EV; Krasil'nikov IV; Ignat'ev GM
    Vopr Virusol; 2010; 55(6):15-9. PubMed ID: 21381334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of a combined live mumps-measles vaccine].
    Unanov SS; Korzh IuN; Dorofeev VM; Iuminova NV; Myshliaeva LA
    Vopr Virusol; 1987; 32(6):715-8. PubMed ID: 3445589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinico-pathogenetic grouping of postvaccinal reactions and complications following smallpox vaccination].
    Bondarev VN
    Vopr Okhr Materin Det; 1971 Aug; 16(8):15-8. PubMed ID: 4402961
    [No Abstract]   [Full Text] [Related]  

  • 18. [The dynamics of the T-lymphocyte subpopulations and the peroxidase activity of the neutrophils in children immunized with a live mumps vaccine].
    Zakharova TR; Bolotovskiĭ VM; Titova NS; Gelikman BG
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Feb; (2):51-5. PubMed ID: 2160767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The protective role of postvaccinal immunity in mumps in children].
    Zheleznikova GF; Ivanova VV; Bekhtereva MK; Gnilevskaia ZU; Monakhova NE; Novozhilova EV; Goleva OV; Sizemov AN
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):42-6. PubMed ID: 10925873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children.
    Pichichero ME; Edwards KM; Anderson EL; Rennels MB; Englund JA; Yerg DE; Blackwelder WC; Jansen DL; Meade BD
    Pediatrics; 2000 Jan; 105(1):e11. PubMed ID: 10617748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.